Shares of Sequenom (SQNM +7%) jump today after Stephens upgraded the stock to Overweight based...
Shares of Sequenom (SQNM +7%) jump today after Stephens upgraded the stock to Overweight based on the American College of Obstetricians and Gynecologists Committee on Genetics recommendation that cell-free fetal DNA testing be used in high-risk women. The firm also doubles its price target to $8 from $4.
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs